These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33112963)

  • 1. [Gastro-oesophageal reflux disease-update 2021].
    Labenz J; Borkenstein DP; Müller M; Labenz G
    Internist (Berl); 2020 Dec; 61(12):1249-1263. PubMed ID: 33112963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease.
    Zerbib F; Belhocine K; Simon M; Capdepont M; Mion F; Bruley des Varannes S; Galmiche JP
    Gut; 2012 Apr; 61(4):501-6. PubMed ID: 21997546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of PPI-resistant gastro-oesophageal reflux: A systematic review.
    Gallusi G; Pontone S
    Arab J Gastroenterol; 2018 Jun; 19(2):51-55. PubMed ID: 29935866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facts and fantasies in extra-oesophageal symptoms in GORD.
    Labenz J
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):893-904. PubMed ID: 21126702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of potent acid inhibition in gastro-oesophageal reflux disease.
    Monés J
    Drugs; 2005; 65 Suppl 1():35-42. PubMed ID: 16335856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The value of twenty-four hour intraoesophageal pH monitoring and manometry in the management of patients with upper gastrointestinal symptoms].
    Lakner L; Döbrönte Z
    Orv Hetil; 2009 Oct; 150(43):1978-82. PubMed ID: 19812019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological management of gastro-oesophageal reflux disease.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Drugs; 1995 May; 49(5):695-710. PubMed ID: 7601011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease.
    Cicala M; Emerenziani S; Guarino MP; Ribolsi M
    World J Gastroenterol; 2013 Oct; 19(39):6529-35. PubMed ID: 24151377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
    Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
    Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of heartburn not responding to proton pump inhibitors.
    Fass R; Sifrim D
    Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis.
    Molina-Infante J; van Rhijn BD
    Best Pract Res Clin Gastroenterol; 2015 Oct; 29(5):749-758. PubMed ID: 26552774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractory gastro-oesophageal reflux disease: diagnosis and management.
    Liu JJ; Saltzman JR
    Drugs; 2009 Oct; 69(14):1935-44. PubMed ID: 19747009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower oesophageal sphincter identification for gastro-oesophageal reflux monitoring: The step-up method revisited with use of basal impedance.
    Mauro A; Franchina M; Consonni D; Penagini R
    United European Gastroenterol J; 2019 Dec; 7(10):1373-1379. PubMed ID: 31839963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined multichannel intraluminal impedance and pH monitoring is helpful in managing children with suspected gastro-oesophageal reflux disease.
    Rossi P; Isoldi S; Mallardo S; Papoff P; Rossetti D; Dilillo A; Oliva S
    Dig Liver Dis; 2018 Sep; 50(9):910-915. PubMed ID: 29724467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art.
    Savarino V; Marabotto E; Zentilin P; Demarzo MG; de Bortoli N; Savarino E
    Drug Des Devel Ther; 2021; 15():1609-1621. PubMed ID: 33907381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.
    Sifrim D; Zerbib F
    Gut; 2012 Sep; 61(9):1340-54. PubMed ID: 22684483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring.
    Mainie I; Tutuian R; Shay S; Vela M; Zhang X; Sifrim D; Castell DO
    Gut; 2006 Oct; 55(10):1398-402. PubMed ID: 16556669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton pump inhibitor failure in gastro-oesophageal reflux disease: a perspective aided by the Gartner hype cycle.
    Heading RC
    Clin Med (Lond); 2017 Apr; 17(2):132-136. PubMed ID: 28365622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.